REFERENCES
- Stewart W. E. II: The Interferon System. Springer-Verlag, Wien 1979; 266–291
- Gresser I., Tovey M. G. Antitumor effects of interferon. Biochim. Biophys. Acta 1978; 516: 231–247
- Hubbel R H., Graft A. J., Leibowitz J. P., Gillespie D. H. Synergistic antiproliferative effect of recombinant alpha-interferons with recombinant gamma-interferons. J. Biol. Resp. Modif. 1987; 6: 141–153
- Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their actions. Annu. Rev. Biochem. 1987; 56: 727–777
- Hansen R. M., Borden E. C. Current status of interferons in the treatment of cancer. Oncol. Hunting 1992; 6: 19–24
- Wedantham S., Gamliel H., Golomb H. M. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy. Cancer Res. 1992; 52: 1056–1066
- Novik D., Cohen B., Rubinstein M. The human interferon α/β receptor: characterization and molecular cloning, Cell. 1994; 77: 391–400
- Takii T., Niki N., Yang D., Kimura H., Ito A., Hayashi H., Onozaki K. Type I and type II interferons upregulate functional type I interleukin-1 receptor in a human fibroblast cell line TIG-1. J. Interferon Cytokine Res. 1995; 15: 1065–1073
- Richmond J. Y. An interferon-like inhibitor of foot-and-mouth disease virus induced by phytohaemagglutinin in swine leukocyte cultures. Arch. Ges. Virusforsch 1969; 27: 282–289
- Soloviev V. D., Pokydisheva L. N., Volodina T. N. On antigenic similarity of some alpha-interferons. Vopr. Virusol 1982; 27: 526–527
- Piasecki E. Properties of natural porcine interferons. J. IFN Res. 1988; 8: 61–73
- Bonnardier C. La, Laube H., Berg K. Biological and antigenic relationship between virus induced porcine and human interferons. Ann. Inst. Pasteur/Virol. 1986; 137E: 171–180
- Filipic B., Golob A., Tóth S., Mécs I., Béládi I., Likar M. Interactions between human and porcine interferons. Acta Virol. 1991; 35: 19–26
- Tóth M., Endrész V., Béládi I., Tóth S.. Verfahren zur nacheinanderfolgenden Herstellung von humanen Leukozyteninterferon und humanen gamma-interferon. European PatentNo. 84115123.6, 1984
- Endrész V., Tóth M., Tóth S., Mándi Y., béláladi I. Priming activity of human interferon types in comparison with their other biological effects. Acta Microbiol. Hung. 1984; 31: 67–71
- Tóth M., Endrész V., Tóth S., béláladi I. Human interferons alpha and beta have more potent priming activities than interferon gamma. J. Gen. Virol. 1985; 66: 893–896
- Suzuki Y., Nagao Y., Kato H., Suzuki T., Matsumota M., Murayama J. The hemagglutinins of the human influenza viruses A and B recognize different receptor microdomains. Biochim Biophys Acta 1987; 903: 417–424
- Kuroya M., Ishida N. Newborn virus pneumonitis (type Sendai) II. Report: The isolation of a new virus possessing hemagglutinin activity. Yokohama Med. Bull 1953; 4: 217–233
- Pretnar G., Filipic B., Golob A., Skodic A., Tóth S., Mécs I., Suhar A. Electroinduction of interferon like proteins. Bioelectrochem Bioenerg 1991; 25: 183–193
- Gachet Y., Carpentier G., Chousterman S. Purification of an atypical bovine interferon-induced in response to heat-shock in bovine cultured cellsμcharacterization in comparison with the classical alpha-interferon and gamma-interferon. Biochimie 1997; 79: 43–52
- Stewart W. E., II, Blalock J. E., Burke D. C., Chany C., Dunnick J. D., Falcoff E., Friedman R. M., Galasso G. J., Joklik W. K., Vilcek J., Youngner J. S., Zoon K. C. Interferon nomenclature. Nature 1980; 286: 110